← Back to catalogue

EnLite Neonatal TREC kit

FDA UDI

Class II (US FDA UDI)

by Wallac, Inc.

Identity

Trade Name
EnLite Neonatal TREC kit FDA UDI
Generic Name
T-cell receptor excision circle (TREC) IVD, kit, nucleic acid technique (NAT) FDA UDI
Device Name
Polymerase chain reaction (PCR) based assay for semiquantitative determination of TREC DNA in dried blood specimens. FDA UDI
Model / Reference
3401-001U FDA UDI
Description
Polymerase chain reaction (PCR) based assay for semiquantitative determination of TREC DNA in dried blood specimens. FDA UDI

Identifiers

Catalog Number
3401-001U FDA UDI
Primary DI / UDI-DI
06438147331802 FDA UDI
510(k) Number
FDA Product Code
PJI FDA UDI
GMDN Term
T-cell receptor excision circle (TREC) IVD, kit, nucleic acid technique (NAT) FDA UDI

Classification

Device Class
Class II FDA UDI
Regulation Number
866.5930 FDA UDI
Commercial Distribution
In Commercial Distribution FDA UDI

Clinical & Handling

Sterile

No

FDA UDI

Single Use

No

FDA UDI

Implantable

No

FDA UDI

Contains Latex

No

FDA UDI

Prescription Use

Yes

FDA UDI

Over-the-Counter

No

FDA UDI

Convenience Kit

Yes

FDA UDI

Combination Product

No

FDA UDI

HCT/P

No

FDA UDI

Premarket Exempt

No

FDA UDI

Lot / Batch Number

Yes

FDA UDI

Serial Number

No

FDA UDI

Expiration Date

Yes

FDA UDI

Manufacturing Date

No

FDA UDI

Category: T-cell receptor excision circle (TREC) IVD, kit, nucleic acid technique (NAT)

EnLite Neonatal TREC kit by Wallac, Inc. — Class II — FDA UDI — listed in FDA GUDID — regulatory data on deviCERTS

Similar devices

Also classified as T-cell receptor excision circle (TREC) IVD, kit, nucleic acid technique (NAT).

Cleared under the same submission

Authorization Coverage (1 country)

Regulatory Authorizations

United States Pending data

FDA UDI

Is this your device? Claim it to add documentation and request validation.

Manufacturer

Manufacturer
Wallac, Inc.

Sources (1)

  • FDA UDI 558bfbeb-a479-41e4-a083-bc08323f596a 36 fields · synced Jun 8, 2026